Newly Developed Self-Assembling Antioxidants as Potential Therapeutics for the Cancers

Babita Shashni1, Yukio Nagasaki1,2,3

  • 1Department of Materials Science, Graduate School of Pure and Applied Sciences, University of Tsukuba, Tennoudai 1-1-1, Tsukuba, Ibaraki 305-8573, Japan.

Insights

New antioxidant nanoparticles effectively target cancer by attenuating reactive oxygen species (ROS). These novel nanoparticles show improved pharmacokinetics and therapeutic effects compared to small molecule antioxidants, with fewer adverse effects in cancer models.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Therapeutics

Background:

  • Elevated reactive oxygen species (ROS) are crucial for cancer cell survival, acting as oncogene activators and secondary messengers.
  • Antioxidant-based therapies targeting ROS signaling pathways represent a promising strategy for cancer treatment.
  • Low molecular weight (LMW) antioxidants like TEMPO have limitations in vivo due to off-target effects and size.

Purpose of the Study:

  • To evaluate the efficacy of a novel TEMPO radical-conjugated self-assembling antioxidant nanoparticle (RNP) compared to LMW TEMPO.
  • To assess the pharmacokinetic advantages, therapeutic effects, and safety profile of RNPs in preclinical cancer models.

Main Methods:

  • Development of TEMPO radical-conjugated self-assembling antioxidant nanoparticles (RNPs).
  • In vitro and in vivo evaluation of RNPs and LMW TEMPO in various cancer models.
  • Assessment of pharmacokinetics, therapeutic efficacy, and adverse effects.

Main Results:

  • RNPs demonstrated superior pharmacokinetics compared to LMW antioxidants.
  • Enhanced therapeutic effects were observed with RNPs in preclinical cancer models.
  • RNPs exhibited a more favorable safety profile with reduced adverse effects.

Conclusions:

  • TEMPO-conjugated antioxidant nanoparticles offer a promising advancement in cancer therapy.
  • RNPs overcome the limitations of LMW antioxidants, providing improved in vivo performance.
  • This nanoparticle-based approach warrants further investigation for clinical translation in oncology.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
17.0K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
2.7K